Akebia Therapeutics
AKBA
AKBA
132 hedge funds and large institutions have $470M invested in Akebia Therapeutics in 2017 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 53 increasing their positions, 33 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
7.31% more ownership
Funds ownership: 63.98% → 71.29% (+7.3%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
21% less capital invested
Capital invested by funds: $593M → $470M (-$123M)
Holders
132
Holding in Top 10
2
Calls
$391K
Puts
$185K
Top Buyers
| 1 | +$8.42M | |
| 2 | +$5.95M | |
| 3 | +$5.31M | |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$5.02M |
| 5 |
JPMorgan Chase & Co
New York
|
+$4.26M |
Top Sellers
| 1 | -$5.81M | |
| 2 | -$5.17M | |
| 3 | -$4.86M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.31M |
| 5 |
Two Sigma Investments
New York
|
-$3.04M |